Savara Balance Sheet
NASDAQ: SVRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Savara financial position
At the end of fiscal 2025, Savara reported total assets of $253.4 million, up 19.1% from a year earlier against total liabilities of $50.3 million. Shareholders' equity stood at $203.1 million, or 80.2% of assets. The company held $33.2 million in cash and equivalents against $29.9 million of debt, a net cash position of $3.3 million.
The current ratio (current assets divided by current liabilities) was 11.85, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.15.
Summary generated from market data by MetaCap's automated system. Methodology
Savara balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 33.18M | 15.13M | 26.59M | 52.10M | 34.01M | 22.88M | 49.80M | 24.30M | 22.12M | 13.37M |
| Short-Term Investments | 202.52M | 181.20M | 135.73M | 73.78M | 127.16M | 59.31M | 71.96M | 86.53M | 72.19M | 0 |
| Total Current Assets | 241.62M | 202.13M | 165.95M | 128.95M | 165.00M | 85.12M | 124.07M | 113.34M | 97.86M | 14.61M |
| Property, Plant & Equipment | 100.00K | 165.00K | 270.00K | 51.00K | 73.00K | 156.00K | 352.00K | 522.00K | 925.00K | 793.00K |
| Goodwill | — | — | — | — | — | 0 | — | 26.92M | 27.08M | 3.05M |
| Total Assets | 253.44M | 212.88M | 177.56M | 139.78M | 176.60M | 97.75M | 136.20M | 152.29M | 159.63M | 28.93M |
| Accounts Payable | 5.76M | 4.54M | 3.50M | 1.33M | 1.44M | 2.60M | 3.41M | 3.88M | 2.78M | 536.00K |
| Short-Term Debt | 0 | 0 | — | — | 8.33M | — | — | — | — | — |
| Total Current Liabilities | 20.40M | 14.72M | 10.60M | 5.87M | 14.66M | 8.17M | 10.88M | 7.25M | 6.01M | 3.46M |
| Long-Term Debt | 29.91M | 26.62M | 26.35M | 26.08M | 17.32M | 25.10M | — | — | — | — |
| Total Liabilities | 50.30M | 41.43M | 37.19M | 32.00M | 32.10M | 33.36M | 34.51M | 44.07M | 40.32M | 20.95M |
| Shareholders' Equity | 203.13M | 171.45M | 140.37M | 107.78M | 144.50M | 64.38M | 101.70M | 108.22M | 119.31M | -35.88M |
| Retained Earnings | -608.09M | -489.25M | -393.37M | -338.67M | -300.52M | -257.51M | -207.89M | -129.72M | -68.20M | -38.41M |
| Total Debt | 29.91M | 26.62M | 26.35M | 26.08M | 25.66M | 25.10M | — | — | — | — |
| Net Cash (Debt) | 205.79M | 169.71M | 135.97M | 99.80M | 135.51M | 57.08M | 121.76M | 110.83M | 94.31M | 13.37M |
| Shares Outstanding | 204.57M | 172.42M | 138.14M | 114.05M | 114.04M | 54.15M | 50.79M | 35.15M | 30.51M | 3.16M |
This table shows 10 annual periods of Savara's balance sheet, from FY 2025 back to FY 2016, across 16 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow SVRA's reporting calendar. What is a balance sheet?